Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel Syndrome
Keywords: شاخص حرکتی; Sensory; Motor; Clinical Trial; Drug Metabolism; FAAH; fatty acid amide hydrolase; IBS-A; irritable bowel syndrome alternating; IBS-C; irritable bowel syndrome with constipation; IBS-D; irritable bowel syndrome with diarrhea; MGLL; monoacylglycerol lipase